nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—Pimozide—Ezetimibe—coronary artery disease	0.286	0.521	CrCrCtD
Droperidol—Fluspirilene—Ezetimibe—coronary artery disease	0.263	0.479	CrCrCtD
Droperidol—HTR2A—coronary artery disease	0.215	1	CbGaD
Droperidol—KCNH2—purkinje fiber—coronary artery disease	0.0229	0.362	CbGeAlD
Droperidol—KCNH2—endocardium—coronary artery disease	0.0118	0.186	CbGeAlD
Droperidol—HTR2A—arteriole—coronary artery disease	0.00489	0.0771	CbGeAlD
Droperidol—HTR2A—pulmonary artery—coronary artery disease	0.0032	0.0505	CbGeAlD
Droperidol—HTR2A—sympathetic nervous system—coronary artery disease	0.00311	0.0491	CbGeAlD
Droperidol—HTR2A—vagus nerve—coronary artery disease	0.00301	0.0476	CbGeAlD
Droperidol—HTR2A—vein—coronary artery disease	0.00291	0.046	CbGeAlD
Droperidol—HTR2A—autonomic nervous system—coronary artery disease	0.00209	0.033	CbGeAlD
Droperidol—HTR2A—artery—coronary artery disease	0.00119	0.0187	CbGeAlD
Droperidol—HTR2A—endothelium—coronary artery disease	0.001	0.0158	CbGeAlD
Droperidol—KCNH2—cardiac ventricle—coronary artery disease	0.000994	0.0157	CbGeAlD
Droperidol—KCNH2—myocardium—coronary artery disease	0.000935	0.0148	CbGeAlD
Droperidol—ADRA1A—heart—coronary artery disease	0.000676	0.0107	CbGeAlD
Droperidol—KCNH2—heart—coronary artery disease	0.000653	0.0103	CbGeAlD
Droperidol—ADRA1A—cardiovascular system—coronary artery disease	0.000638	0.0101	CbGeAlD
Droperidol—KCNH2—cardiovascular system—coronary artery disease	0.000616	0.00972	CbGeAlD
Droperidol—KCNH2—cardiac atrium—coronary artery disease	0.000558	0.00881	CbGeAlD
Droperidol—ADRA1A—blood—coronary artery disease	0.000504	0.00796	CbGeAlD
Droperidol—KCNH2—blood—coronary artery disease	0.000487	0.00769	CbGeAlD
Droperidol—HTR2A—heart—coronary artery disease	0.000437	0.00689	CbGeAlD
Droperidol—HTR2A—cardiovascular system—coronary artery disease	0.000412	0.00651	CbGeAlD
Droperidol—Fluspirilene—ADRB1—coronary artery disease	0.000404	0.242	CrCbGaD
Droperidol—HTR2A—blood—coronary artery disease	0.000326	0.00514	CbGeAlD
Droperidol—Fenbufen—PTGS2—coronary artery disease	0.000268	0.161	CrCbGaD
Droperidol—Angioedema—Olmesartan—coronary artery disease	0.000261	0.00243	CcSEcCtD
Droperidol—Anaphylactic shock—Ezetimibe—coronary artery disease	0.00026	0.00242	CcSEcCtD
Droperidol—Anxiety—Simvastatin—coronary artery disease	0.000258	0.0024	CcSEcCtD
Droperidol—Syncope—Valsartan—coronary artery disease	0.000257	0.00239	CcSEcCtD
Droperidol—Syncope—Olmesartan—coronary artery disease	0.000256	0.00238	CcSEcCtD
Droperidol—Hypersensitivity—Ticagrelor—coronary artery disease	0.000256	0.00238	CcSEcCtD
Droperidol—Chills—Perindopril—coronary artery disease	0.000255	0.00237	CcSEcCtD
Droperidol—Angioedema—Niacin—coronary artery disease	0.000255	0.00237	CcSEcCtD
Droperidol—Bronchospasm—Lisinopril—coronary artery disease	0.000255	0.00237	CcSEcCtD
Droperidol—Hypotension—Fenofibrate—coronary artery disease	0.000254	0.00236	CcSEcCtD
Droperidol—Palpitations—Valsartan—coronary artery disease	0.000254	0.00236	CcSEcCtD
Droperidol—Palpitations—Olmesartan—coronary artery disease	0.000252	0.00235	CcSEcCtD
Droperidol—Loss of consciousness—Valsartan—coronary artery disease	0.000252	0.00235	CcSEcCtD
Droperidol—Hyperglycaemia—Timolol—coronary artery disease	0.000252	0.00234	CcSEcCtD
Droperidol—Angioedema—Pravastatin—coronary artery disease	0.000251	0.00234	CcSEcCtD
Droperidol—Loss of consciousness—Olmesartan—coronary artery disease	0.000251	0.00234	CcSEcCtD
Droperidol—Shock—Eplerenone—coronary artery disease	0.00025	0.00233	CcSEcCtD
Droperidol—Syncope—Niacin—coronary artery disease	0.00025	0.00233	CcSEcCtD
Droperidol—Hypotension—Clopidogrel—coronary artery disease	0.000249	0.00232	CcSEcCtD
Droperidol—Depression—Timolol—coronary artery disease	0.000248	0.00231	CcSEcCtD
Droperidol—Anaphylactic shock—Simvastatin—coronary artery disease	0.000248	0.00231	CcSEcCtD
Droperidol—Palpitations—Niacin—coronary artery disease	0.000247	0.00229	CcSEcCtD
Droperidol—Loss of consciousness—Niacin—coronary artery disease	0.000245	0.00228	CcSEcCtD
Droperidol—Angioedema—Trandolapril—coronary artery disease	0.000244	0.00227	CcSEcCtD
Droperidol—Anxiety—Valsartan—coronary artery disease	0.000243	0.00227	CcSEcCtD
Droperidol—Angioedema—Enalapril—coronary artery disease	0.000243	0.00226	CcSEcCtD
Droperidol—Anxiety—Olmesartan—coronary artery disease	0.000242	0.00225	CcSEcCtD
Droperidol—Somnolence—Fenofibrate—coronary artery disease	0.000241	0.00225	CcSEcCtD
Droperidol—Angioedema—Telmisartan—coronary artery disease	0.000239	0.00223	CcSEcCtD
Droperidol—Syncope—Trandolapril—coronary artery disease	0.000239	0.00223	CcSEcCtD
Droperidol—Syncope—Enalapril—coronary artery disease	0.000238	0.00222	CcSEcCtD
Droperidol—Hypotension—Eplerenone—coronary artery disease	0.000238	0.00221	CcSEcCtD
Droperidol—Fluspirilene—HTR2A—coronary artery disease	0.000237	0.142	CrCbGaD
Droperidol—Hypertension—Pravastatin—coronary artery disease	0.000237	0.00221	CcSEcCtD
Droperidol—Palpitations—Trandolapril—coronary artery disease	0.000236	0.00219	CcSEcCtD
Droperidol—Dizziness—Gemfibrozil—coronary artery disease	0.000235	0.00219	CcSEcCtD
Droperidol—Syncope—Telmisartan—coronary artery disease	0.000235	0.00219	CcSEcCtD
Droperidol—Palpitations—Enalapril—coronary artery disease	0.000235	0.00219	CcSEcCtD
Droperidol—Loss of consciousness—Trandolapril—coronary artery disease	0.000234	0.00218	CcSEcCtD
Droperidol—Anaphylactic shock—Valsartan—coronary artery disease	0.000234	0.00218	CcSEcCtD
Droperidol—Hyperglycaemia—Lisinopril—coronary artery disease	0.000234	0.00217	CcSEcCtD
Droperidol—Loss of consciousness—Enalapril—coronary artery disease	0.000234	0.00217	CcSEcCtD
Droperidol—Anxiety—Pravastatin—coronary artery disease	0.000233	0.00217	CcSEcCtD
Droperidol—Anaphylactic shock—Olmesartan—coronary artery disease	0.000233	0.00217	CcSEcCtD
Droperidol—Angioedema—Captopril—coronary artery disease	0.000233	0.00217	CcSEcCtD
Droperidol—Palpitations—Telmisartan—coronary artery disease	0.000232	0.00216	CcSEcCtD
Droperidol—Hypersensitivity—Rosuvastatin—coronary artery disease	0.000231	0.00215	CcSEcCtD
Droperidol—Shock—Valsartan—coronary artery disease	0.00023	0.00214	CcSEcCtD
Droperidol—Loss of consciousness—Telmisartan—coronary artery disease	0.00023	0.00214	CcSEcCtD
Droperidol—Depression—Lisinopril—coronary artery disease	0.00023	0.00214	CcSEcCtD
Droperidol—Dizziness—Ticagrelor—coronary artery disease	0.00023	0.00214	CcSEcCtD
Droperidol—Shock—Olmesartan—coronary artery disease	0.000229	0.00213	CcSEcCtD
Droperidol—Syncope—Captopril—coronary artery disease	0.000229	0.00213	CcSEcCtD
Droperidol—Anaphylactic shock—Niacin—coronary artery disease	0.000228	0.00212	CcSEcCtD
Droperidol—Tachycardia—Olmesartan—coronary artery disease	0.000227	0.00212	CcSEcCtD
Droperidol—Anxiety—Trandolapril—coronary artery disease	0.000226	0.00211	CcSEcCtD
Droperidol—Hypertension—Telmisartan—coronary artery disease	0.000226	0.00211	CcSEcCtD
Droperidol—Angioedema—Perindopril—coronary artery disease	0.000226	0.0021	CcSEcCtD
Droperidol—Palpitations—Captopril—coronary artery disease	0.000225	0.0021	CcSEcCtD
Droperidol—Rash—Gemfibrozil—coronary artery disease	0.000224	0.00209	CcSEcCtD
Droperidol—Anaphylactic shock—Pravastatin—coronary artery disease	0.000224	0.00209	CcSEcCtD
Droperidol—Dermatitis—Gemfibrozil—coronary artery disease	0.000224	0.00209	CcSEcCtD
Droperidol—Shock—Niacin—coronary artery disease	0.000224	0.00208	CcSEcCtD
Droperidol—Loss of consciousness—Captopril—coronary artery disease	0.000224	0.00208	CcSEcCtD
Droperidol—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000224	0.00208	CcSEcCtD
Droperidol—Hallucination—Timolol—coronary artery disease	0.000222	0.00207	CcSEcCtD
Droperidol—Anxiety—Telmisartan—coronary artery disease	0.000222	0.00207	CcSEcCtD
Droperidol—Tachycardia—Niacin—coronary artery disease	0.000222	0.00207	CcSEcCtD
Droperidol—Syncope—Perindopril—coronary artery disease	0.000222	0.00206	CcSEcCtD
Droperidol—Rash—Ticagrelor—coronary artery disease	0.000219	0.00204	CcSEcCtD
Droperidol—Dermatitis—Ticagrelor—coronary artery disease	0.000219	0.00204	CcSEcCtD
Droperidol—Hypotension—Valsartan—coronary artery disease	0.000219	0.00204	CcSEcCtD
Droperidol—Pimozide—CYP2C19—coronary artery disease	0.000219	0.131	CrCbGaD
Droperidol—Palpitations—Perindopril—coronary artery disease	0.000219	0.00203	CcSEcCtD
Droperidol—Hypotension—Olmesartan—coronary artery disease	0.000218	0.00203	CcSEcCtD
Droperidol—Loss of consciousness—Perindopril—coronary artery disease	0.000217	0.00202	CcSEcCtD
Droperidol—Anaphylactic shock—Enalapril—coronary artery disease	0.000217	0.00202	CcSEcCtD
Droperidol—Body temperature increased—Fenofibrate—coronary artery disease	0.000215	0.002	CcSEcCtD
Droperidol—Shock—Trandolapril—coronary artery disease	0.000214	0.00199	CcSEcCtD
Droperidol—Anaphylactic shock—Telmisartan—coronary artery disease	0.000214	0.00199	CcSEcCtD
Droperidol—Hypertension—Perindopril—coronary artery disease	0.000214	0.00199	CcSEcCtD
Droperidol—Shock—Enalapril—coronary artery disease	0.000213	0.00199	CcSEcCtD
Droperidol—Hypotension—Niacin—coronary artery disease	0.000213	0.00198	CcSEcCtD
Droperidol—Tachycardia—Trandolapril—coronary artery disease	0.000213	0.00198	CcSEcCtD
Droperidol—Angioedema—Losartan—coronary artery disease	0.000212	0.00197	CcSEcCtD
Droperidol—Tachycardia—Enalapril—coronary artery disease	0.000212	0.00197	CcSEcCtD
Droperidol—Body temperature increased—Clopidogrel—coronary artery disease	0.000211	0.00196	CcSEcCtD
Droperidol—Shock—Telmisartan—coronary artery disease	0.00021	0.00196	CcSEcCtD
Droperidol—Anxiety—Perindopril—coronary artery disease	0.00021	0.00195	CcSEcCtD
Droperidol—Body temperature increased—Lovastatin—coronary artery disease	0.00021	0.00195	CcSEcCtD
Droperidol—Tachycardia—Telmisartan—coronary artery disease	0.000209	0.00194	CcSEcCtD
Droperidol—Somnolence—Valsartan—coronary artery disease	0.000208	0.00194	CcSEcCtD
Droperidol—Syncope—Losartan—coronary artery disease	0.000208	0.00194	CcSEcCtD
Droperidol—Anaphylactic shock—Captopril—coronary artery disease	0.000208	0.00194	CcSEcCtD
Droperidol—Dizziness—Rosuvastatin—coronary artery disease	0.000207	0.00193	CcSEcCtD
Droperidol—Hallucination—Lisinopril—coronary artery disease	0.000206	0.00192	CcSEcCtD
Droperidol—Body temperature increased—Ezetimibe—coronary artery disease	0.000206	0.00191	CcSEcCtD
Droperidol—Palpitations—Losartan—coronary artery disease	0.000205	0.00191	CcSEcCtD
Droperidol—Shock—Captopril—coronary artery disease	0.000205	0.0019	CcSEcCtD
Droperidol—Loss of consciousness—Losartan—coronary artery disease	0.000204	0.0019	CcSEcCtD
Droperidol—Hypotension—Trandolapril—coronary artery disease	0.000203	0.00189	CcSEcCtD
Droperidol—Tachycardia—Captopril—coronary artery disease	0.000203	0.00189	CcSEcCtD
Droperidol—Hypotension—Enalapril—coronary artery disease	0.000203	0.00189	CcSEcCtD
Droperidol—Somnolence—Niacin—coronary artery disease	0.000202	0.00188	CcSEcCtD
Droperidol—Anaphylactic shock—Perindopril—coronary artery disease	0.000202	0.00188	CcSEcCtD
Droperidol—Body temperature increased—Eplerenone—coronary artery disease	0.000201	0.00187	CcSEcCtD
Droperidol—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000201	0.00187	CcSEcCtD
Droperidol—Hypersensitivity—Fenofibrate—coronary artery disease	0.0002	0.00186	CcSEcCtD
Droperidol—Hypotension—Telmisartan—coronary artery disease	0.0002	0.00186	CcSEcCtD
Droperidol—Haloperidol—CYP2C19—coronary artery disease	0.0002	0.12	CrCbGaD
Droperidol—Shock—Perindopril—coronary artery disease	0.000199	0.00185	CcSEcCtD
Droperidol—Rash—Rosuvastatin—coronary artery disease	0.000197	0.00184	CcSEcCtD
Droperidol—Tachycardia—Perindopril—coronary artery disease	0.000197	0.00183	CcSEcCtD
Droperidol—Dermatitis—Rosuvastatin—coronary artery disease	0.000197	0.00183	CcSEcCtD
Droperidol—Anxiety—Losartan—coronary artery disease	0.000197	0.00183	CcSEcCtD
Droperidol—Hypersensitivity—Clopidogrel—coronary artery disease	0.000197	0.00183	CcSEcCtD
Droperidol—Anaphylactic shock—Furosemide—coronary artery disease	0.000196	0.00183	CcSEcCtD
Droperidol—Body temperature increased—Simvastatin—coronary artery disease	0.000196	0.00182	CcSEcCtD
Droperidol—Hypersensitivity—Lovastatin—coronary artery disease	0.000195	0.00182	CcSEcCtD
Droperidol—Hypotension—Captopril—coronary artery disease	0.000194	0.00181	CcSEcCtD
Droperidol—Somnolence—Trandolapril—coronary artery disease	0.000194	0.0018	CcSEcCtD
Droperidol—Shock—Furosemide—coronary artery disease	0.000193	0.0018	CcSEcCtD
Droperidol—Somnolence—Enalapril—coronary artery disease	0.000193	0.00179	CcSEcCtD
Droperidol—Rash—Acetylsalicylic acid—coronary artery disease	0.000192	0.00178	CcSEcCtD
Droperidol—Hypersensitivity—Ezetimibe—coronary artery disease	0.000192	0.00178	CcSEcCtD
Droperidol—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000191	0.00178	CcSEcCtD
Droperidol—Somnolence—Telmisartan—coronary artery disease	0.00019	0.00177	CcSEcCtD
Droperidol—Anaphylactic shock—Losartan—coronary artery disease	0.000189	0.00176	CcSEcCtD
Droperidol—Hypotension—Perindopril—coronary artery disease	0.000189	0.00176	CcSEcCtD
Droperidol—Shock—Losartan—coronary artery disease	0.000186	0.00173	CcSEcCtD
Droperidol—Chills—Lisinopril—coronary artery disease	0.000186	0.00173	CcSEcCtD
Droperidol—Somnolence—Captopril—coronary artery disease	0.000185	0.00172	CcSEcCtD
Droperidol—Tachycardia—Losartan—coronary artery disease	0.000185	0.00172	CcSEcCtD
Droperidol—Body temperature increased—Olmesartan—coronary artery disease	0.000184	0.00171	CcSEcCtD
Droperidol—Hypotension—Furosemide—coronary artery disease	0.000183	0.00171	CcSEcCtD
Droperidol—Hypersensitivity—Simvastatin—coronary artery disease	0.000183	0.0017	CcSEcCtD
Droperidol—Angioedema—Ramipril—coronary artery disease	0.000182	0.00169	CcSEcCtD
Droperidol—Body temperature increased—Niacin—coronary artery disease	0.00018	0.00168	CcSEcCtD
Droperidol—Dizziness—Fenofibrate—coronary artery disease	0.00018	0.00167	CcSEcCtD
Droperidol—Somnolence—Perindopril—coronary artery disease	0.00018	0.00167	CcSEcCtD
Droperidol—Syncope—Ramipril—coronary artery disease	0.000178	0.00166	CcSEcCtD
Droperidol—Angioedema—Timolol—coronary artery disease	0.000178	0.00165	CcSEcCtD
Droperidol—Pimozide—HTR2A—coronary artery disease	0.000177	0.106	CrCbGaD
Droperidol—Body temperature increased—Pravastatin—coronary artery disease	0.000177	0.00165	CcSEcCtD
Droperidol—Hypotension—Losartan—coronary artery disease	0.000177	0.00165	CcSEcCtD
Droperidol—Dizziness—Clopidogrel—coronary artery disease	0.000177	0.00164	CcSEcCtD
Droperidol—Palpitations—Ramipril—coronary artery disease	0.000176	0.00164	CcSEcCtD
Droperidol—Dizziness—Lovastatin—coronary artery disease	0.000175	0.00163	CcSEcCtD
Droperidol—Loss of consciousness—Ramipril—coronary artery disease	0.000175	0.00163	CcSEcCtD
Droperidol—Somnolence—Furosemide—coronary artery disease	0.000175	0.00162	CcSEcCtD
Droperidol—Syncope—Timolol—coronary artery disease	0.000174	0.00162	CcSEcCtD
Droperidol—Hypersensitivity—Valsartan—coronary artery disease	0.000173	0.00161	CcSEcCtD
Droperidol—Body temperature increased—Trandolapril—coronary artery disease	0.000172	0.0016	CcSEcCtD
Droperidol—Dizziness—Ezetimibe—coronary artery disease	0.000172	0.0016	CcSEcCtD
Droperidol—Palpitations—Timolol—coronary artery disease	0.000172	0.0016	CcSEcCtD
Droperidol—Body temperature increased—Enalapril—coronary artery disease	0.000171	0.0016	CcSEcCtD
Droperidol—Rash—Fenofibrate—coronary artery disease	0.000171	0.00159	CcSEcCtD
Droperidol—Dermatitis—Fenofibrate—coronary artery disease	0.000171	0.00159	CcSEcCtD
Droperidol—Loss of consciousness—Timolol—coronary artery disease	0.000171	0.00159	CcSEcCtD
Droperidol—Body temperature increased—Telmisartan—coronary artery disease	0.000169	0.00157	CcSEcCtD
Droperidol—Anxiety—Ramipril—coronary artery disease	0.000169	0.00157	CcSEcCtD
Droperidol—Somnolence—Losartan—coronary artery disease	0.000168	0.00157	CcSEcCtD
Droperidol—Dizziness—Eplerenone—coronary artery disease	0.000168	0.00157	CcSEcCtD
Droperidol—Rash—Clopidogrel—coronary artery disease	0.000168	0.00157	CcSEcCtD
Droperidol—Dermatitis—Clopidogrel—coronary artery disease	0.000168	0.00156	CcSEcCtD
Droperidol—Hypertension—Timolol—coronary artery disease	0.000168	0.00156	CcSEcCtD
Droperidol—Hypersensitivity—Niacin—coronary artery disease	0.000168	0.00156	CcSEcCtD
Droperidol—Rash—Lovastatin—coronary artery disease	0.000167	0.00156	CcSEcCtD
Droperidol—Dermatitis—Lovastatin—coronary artery disease	0.000167	0.00155	CcSEcCtD
Droperidol—Hypersensitivity—Pravastatin—coronary artery disease	0.000165	0.00154	CcSEcCtD
Droperidol—Anxiety—Timolol—coronary artery disease	0.000165	0.00154	CcSEcCtD
Droperidol—Angioedema—Lisinopril—coronary artery disease	0.000165	0.00153	CcSEcCtD
Droperidol—Body temperature increased—Captopril—coronary artery disease	0.000164	0.00153	CcSEcCtD
Droperidol—Dizziness—Simvastatin—coronary artery disease	0.000164	0.00153	CcSEcCtD
Droperidol—Rash—Ezetimibe—coronary artery disease	0.000164	0.00153	CcSEcCtD
Droperidol—Dermatitis—Ezetimibe—coronary artery disease	0.000164	0.00152	CcSEcCtD
Droperidol—Anaphylactic shock—Ramipril—coronary artery disease	0.000162	0.00151	CcSEcCtD
Droperidol—Haloperidol—HTR2A—coronary artery disease	0.000162	0.0971	CrCbGaD
Droperidol—Syncope—Lisinopril—coronary artery disease	0.000162	0.00151	CcSEcCtD
Droperidol—Rash—Eplerenone—coronary artery disease	0.00016	0.00149	CcSEcCtD
Droperidol—Hypersensitivity—Trandolapril—coronary artery disease	0.00016	0.00149	CcSEcCtD
Droperidol—Dermatitis—Eplerenone—coronary artery disease	0.00016	0.00149	CcSEcCtD
Droperidol—Shock—Ramipril—coronary artery disease	0.00016	0.00149	CcSEcCtD
Droperidol—Hypersensitivity—Enalapril—coronary artery disease	0.00016	0.00149	CcSEcCtD
Droperidol—Body temperature increased—Perindopril—coronary artery disease	0.00016	0.00149	CcSEcCtD
Droperidol—Palpitations—Lisinopril—coronary artery disease	0.000159	0.00148	CcSEcCtD
Droperidol—Anaphylactic shock—Timolol—coronary artery disease	0.000159	0.00148	CcSEcCtD
Droperidol—Loss of consciousness—Lisinopril—coronary artery disease	0.000159	0.00148	CcSEcCtD
Droperidol—Tachycardia—Ramipril—coronary artery disease	0.000159	0.00148	CcSEcCtD
Droperidol—Hypersensitivity—Telmisartan—coronary artery disease	0.000158	0.00147	CcSEcCtD
Droperidol—Rash—Simvastatin—coronary artery disease	0.000156	0.00146	CcSEcCtD
Droperidol—Dermatitis—Simvastatin—coronary artery disease	0.000156	0.00145	CcSEcCtD
Droperidol—Shock—Timolol—coronary artery disease	0.000156	0.00145	CcSEcCtD
Droperidol—Body temperature increased—Furosemide—coronary artery disease	0.000155	0.00144	CcSEcCtD
Droperidol—Dizziness—Valsartan—coronary artery disease	0.000155	0.00144	CcSEcCtD
Droperidol—Dizziness—Olmesartan—coronary artery disease	0.000154	0.00143	CcSEcCtD
Droperidol—Anxiety—Lisinopril—coronary artery disease	0.000153	0.00142	CcSEcCtD
Droperidol—Hypotension—Ramipril—coronary artery disease	0.000152	0.00141	CcSEcCtD
Droperidol—Dizziness—Niacin—coronary artery disease	0.000151	0.0014	CcSEcCtD
Droperidol—Body temperature increased—Losartan—coronary artery disease	0.00015	0.00139	CcSEcCtD
Droperidol—Hypotension—Timolol—coronary artery disease	0.000148	0.00138	CcSEcCtD
Droperidol—Dizziness—Pravastatin—coronary artery disease	0.000148	0.00138	CcSEcCtD
Droperidol—Rash—Valsartan—coronary artery disease	0.000148	0.00137	CcSEcCtD
Droperidol—Dermatitis—Valsartan—coronary artery disease	0.000148	0.00137	CcSEcCtD
Droperidol—Anaphylactic shock—Lisinopril—coronary artery disease	0.000147	0.00137	CcSEcCtD
Droperidol—Rash—Olmesartan—coronary artery disease	0.000147	0.00137	CcSEcCtD
Droperidol—Dermatitis—Olmesartan—coronary artery disease	0.000147	0.00137	CcSEcCtD
Droperidol—Shock—Lisinopril—coronary artery disease	0.000145	0.00135	CcSEcCtD
Droperidol—Hypersensitivity—Furosemide—coronary artery disease	0.000145	0.00135	CcSEcCtD
Droperidol—Somnolence—Ramipril—coronary artery disease	0.000144	0.00134	CcSEcCtD
Droperidol—Dizziness—Trandolapril—coronary artery disease	0.000144	0.00134	CcSEcCtD
Droperidol—Tachycardia—Lisinopril—coronary artery disease	0.000144	0.00134	CcSEcCtD
Droperidol—Rash—Niacin—coronary artery disease	0.000144	0.00134	CcSEcCtD
Droperidol—Dermatitis—Niacin—coronary artery disease	0.000143	0.00133	CcSEcCtD
Droperidol—Dizziness—Enalapril—coronary artery disease	0.000143	0.00133	CcSEcCtD
Droperidol—Dizziness—Telmisartan—coronary artery disease	0.000141	0.00132	CcSEcCtD
Droperidol—Rash—Pravastatin—coronary artery disease	0.000141	0.00132	CcSEcCtD
Droperidol—Dermatitis—Pravastatin—coronary artery disease	0.000141	0.00131	CcSEcCtD
Droperidol—Somnolence—Timolol—coronary artery disease	0.000141	0.00131	CcSEcCtD
Droperidol—Hypersensitivity—Losartan—coronary artery disease	0.00014	0.0013	CcSEcCtD
Droperidol—Hypotension—Lisinopril—coronary artery disease	0.000138	0.00128	CcSEcCtD
Droperidol—Dizziness—Captopril—coronary artery disease	0.000138	0.00128	CcSEcCtD
Droperidol—Rash—Trandolapril—coronary artery disease	0.000137	0.00128	CcSEcCtD
Droperidol—Dermatitis—Trandolapril—coronary artery disease	0.000137	0.00128	CcSEcCtD
Droperidol—Rash—Enalapril—coronary artery disease	0.000137	0.00127	CcSEcCtD
Droperidol—Dermatitis—Enalapril—coronary artery disease	0.000137	0.00127	CcSEcCtD
Droperidol—Rash—Telmisartan—coronary artery disease	0.000135	0.00126	CcSEcCtD
Droperidol—Dermatitis—Telmisartan—coronary artery disease	0.000135	0.00125	CcSEcCtD
Droperidol—Dizziness—Perindopril—coronary artery disease	0.000134	0.00124	CcSEcCtD
Droperidol—Rash—Captopril—coronary artery disease	0.000131	0.00122	CcSEcCtD
Droperidol—Dermatitis—Captopril—coronary artery disease	0.000131	0.00122	CcSEcCtD
Droperidol—Somnolence—Lisinopril—coronary artery disease	0.000131	0.00122	CcSEcCtD
Droperidol—Dizziness—Furosemide—coronary artery disease	0.00013	0.00121	CcSEcCtD
Droperidol—Body temperature increased—Ramipril—coronary artery disease	0.000128	0.00119	CcSEcCtD
Droperidol—Rash—Perindopril—coronary artery disease	0.000127	0.00118	CcSEcCtD
Droperidol—Dermatitis—Perindopril—coronary artery disease	0.000127	0.00118	CcSEcCtD
Droperidol—Body temperature increased—Timolol—coronary artery disease	0.000126	0.00117	CcSEcCtD
Droperidol—Dizziness—Losartan—coronary artery disease	0.000125	0.00117	CcSEcCtD
Droperidol—Rash—Furosemide—coronary artery disease	0.000124	0.00115	CcSEcCtD
Droperidol—Dermatitis—Furosemide—coronary artery disease	0.000124	0.00115	CcSEcCtD
Droperidol—Hypersensitivity—Ramipril—coronary artery disease	0.00012	0.00111	CcSEcCtD
Droperidol—Rash—Losartan—coronary artery disease	0.000119	0.00111	CcSEcCtD
Droperidol—Dermatitis—Losartan—coronary artery disease	0.000119	0.00111	CcSEcCtD
Droperidol—Hypersensitivity—Timolol—coronary artery disease	0.000117	0.00109	CcSEcCtD
Droperidol—Body temperature increased—Lisinopril—coronary artery disease	0.000116	0.00108	CcSEcCtD
Droperidol—Hypersensitivity—Lisinopril—coronary artery disease	0.000109	0.00101	CcSEcCtD
Droperidol—Dizziness—Ramipril—coronary artery disease	0.000107	0.000999	CcSEcCtD
Droperidol—Dizziness—Timolol—coronary artery disease	0.000105	0.000977	CcSEcCtD
Droperidol—Rash—Ramipril—coronary artery disease	0.000102	0.000953	CcSEcCtD
Droperidol—Dermatitis—Ramipril—coronary artery disease	0.000102	0.000952	CcSEcCtD
Droperidol—Rash—Timolol—coronary artery disease	0.0001	0.000932	CcSEcCtD
Droperidol—Dermatitis—Timolol—coronary artery disease	0.0001	0.000931	CcSEcCtD
Droperidol—Dizziness—Lisinopril—coronary artery disease	9.74e-05	0.000906	CcSEcCtD
Droperidol—Rash—Lisinopril—coronary artery disease	9.29e-05	0.000864	CcSEcCtD
Droperidol—Dermatitis—Lisinopril—coronary artery disease	9.28e-05	0.000863	CcSEcCtD
Droperidol—ADRA1A—Signaling Pathways—ADRB1—coronary artery disease	8.68e-06	0.000139	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CYBA—coronary artery disease	8.68e-06	0.000139	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLAT—coronary artery disease	8.68e-06	0.000139	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DUSP6—coronary artery disease	8.65e-06	0.000138	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—BDKRB2—coronary artery disease	8.51e-06	0.000136	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL12—coronary artery disease	8.51e-06	0.000136	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLAT—coronary artery disease	8.5e-06	0.000136	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—POMC—coronary artery disease	8.5e-06	0.000136	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—F2—coronary artery disease	8.47e-06	0.000136	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6ST—coronary artery disease	8.44e-06	0.000135	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL12—coronary artery disease	8.38e-06	0.000134	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—BDKRB2—coronary artery disease	8.38e-06	0.000134	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—POMC—coronary artery disease	8.36e-06	0.000134	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—JUNB—coronary artery disease	8.36e-06	0.000134	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—F2—coronary artery disease	8.34e-06	0.000134	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLCB1—coronary artery disease	8.33e-06	0.000133	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6ST—coronary artery disease	8.3e-06	0.000133	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—JUNB—coronary artery disease	8.22e-06	0.000132	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL12—coronary artery disease	8.2e-06	0.000131	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—BDKRB2—coronary artery disease	8.2e-06	0.000131	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLCB1—coronary artery disease	8.19e-06	0.000131	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—POMC—coronary artery disease	8.19e-06	0.000131	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—F2—coronary artery disease	8.16e-06	0.000131	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR7—coronary artery disease	8.15e-06	0.000131	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6ST—coronary artery disease	8.13e-06	0.00013	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—JUNB—coronary artery disease	8.05e-06	0.000129	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLCB1—coronary artery disease	8.02e-06	0.000128	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HTR7—coronary artery disease	8.02e-06	0.000128	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR7—coronary artery disease	7.85e-06	0.000126	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ITGAV—coronary artery disease	7.77e-06	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KNG1—coronary artery disease	7.74e-06	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CREB1—coronary artery disease	7.72e-06	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—POMC—coronary artery disease	7.72e-06	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGTR1—coronary artery disease	7.7e-06	0.000123	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ITGAV—coronary artery disease	7.64e-06	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KNG1—coronary artery disease	7.62e-06	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—POMC—coronary artery disease	7.6e-06	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CREB1—coronary artery disease	7.6e-06	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGTR1—coronary artery disease	7.57e-06	0.000121	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCL2—coronary artery disease	7.55e-06	0.000121	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6R—coronary artery disease	7.53e-06	0.000121	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL10—coronary artery disease	7.52e-06	0.00012	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLG—coronary artery disease	7.5e-06	0.00012	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ITGAV—coronary artery disease	7.48e-06	0.00012	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KNG1—coronary artery disease	7.46e-06	0.00012	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—POMC—coronary artery disease	7.44e-06	0.000119	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CREB1—coronary artery disease	7.44e-06	0.000119	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL2—coronary artery disease	7.43e-06	0.000119	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGTR1—coronary artery disease	7.42e-06	0.000119	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6R—coronary artery disease	7.41e-06	0.000119	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL10—coronary artery disease	7.4e-06	0.000119	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLG—coronary artery disease	7.38e-06	0.000118	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB2—coronary artery disease	7.3e-06	0.000117	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL2—coronary artery disease	7.28e-06	0.000117	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6R—coronary artery disease	7.25e-06	0.000116	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL10—coronary artery disease	7.25e-06	0.000116	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLG—coronary artery disease	7.23e-06	0.000116	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCE—coronary artery disease	7.21e-06	0.000115	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—JAK2—coronary artery disease	7.2e-06	0.000115	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SOCS1—coronary artery disease	7.19e-06	0.000115	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB2—coronary artery disease	7.19e-06	0.000115	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—S100B—coronary artery disease	7.17e-06	0.000115	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SOCS3—coronary artery disease	7.1e-06	0.000114	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCE—coronary artery disease	7.09e-06	0.000114	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—JAK2—coronary artery disease	7.09e-06	0.000114	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SOCS1—coronary artery disease	7.08e-06	0.000113	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—S100B—coronary artery disease	7.06e-06	0.000113	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB2—coronary artery disease	7.04e-06	0.000113	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFBR2—coronary artery disease	7.02e-06	0.000112	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KITLG—coronary artery disease	7.02e-06	0.000112	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SOCS3—coronary artery disease	6.99e-06	0.000112	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	6.95e-06	0.000111	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	6.94e-06	0.000111	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	6.93e-06	0.000111	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—S100B—coronary artery disease	6.91e-06	0.000111	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KITLG—coronary artery disease	6.91e-06	0.000111	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFBR2—coronary artery disease	6.91e-06	0.000111	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STAT5A—coronary artery disease	6.86e-06	0.00011	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP3—coronary artery disease	6.86e-06	0.00011	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	6.84e-06	0.00011	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	6.76e-06	0.000108	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	6.76e-06	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STAT5A—coronary artery disease	6.75e-06	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP3—coronary artery disease	6.75e-06	0.000108	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOB—coronary artery disease	6.63e-06	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	6.61e-06	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	6.61e-06	0.000106	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL8—coronary artery disease	6.58e-06	0.000105	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—JAK2—coronary artery disease	6.54e-06	0.000105	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EDN1—coronary artery disease	6.53e-06	0.000105	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOB—coronary artery disease	6.53e-06	0.000105	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL5—coronary artery disease	6.48e-06	0.000104	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL8—coronary artery disease	6.47e-06	0.000104	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—JAK2—coronary artery disease	6.44e-06	0.000103	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EDN1—coronary artery disease	6.42e-06	0.000103	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOB—coronary artery disease	6.39e-06	0.000102	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF1—coronary artery disease	6.38e-06	0.000102	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CSF2—coronary artery disease	6.38e-06	0.000102	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL5—coronary artery disease	6.37e-06	0.000102	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	6.34e-06	0.000101	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LPL—coronary artery disease	6.33e-06	0.000101	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	6.3e-06	0.000101	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	6.29e-06	0.000101	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF1—coronary artery disease	6.28e-06	0.000101	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CSF2—coronary artery disease	6.28e-06	0.000101	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MEF2C—coronary artery disease	6.28e-06	0.000101	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RPS6KB1—coronary artery disease	6.28e-06	0.000101	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	6.24e-06	9.99e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LPL—coronary artery disease	6.23e-06	9.98e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RPS6KB1—coronary artery disease	6.18e-06	9.89e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MEF2C—coronary artery disease	6.18e-06	9.89e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	6.15e-06	9.84e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	6.15e-06	9.84e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ITGB3—coronary artery disease	6.12e-06	9.8e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LPL—coronary artery disease	6.1e-06	9.77e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	6.05e-06	9.68e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	6.05e-06	9.68e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ITGB3—coronary artery disease	6.02e-06	9.64e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL8—coronary artery disease	5.97e-06	9.56e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PPP2CA—coronary artery disease	5.94e-06	9.52e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	5.89e-06	9.44e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL8—coronary artery disease	5.88e-06	9.41e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PPP2CA—coronary artery disease	5.85e-06	9.36e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCD—coronary artery disease	5.83e-06	9.34e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	5.75e-06	9.21e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCD—coronary artery disease	5.74e-06	9.19e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	5.72e-06	9.17e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR2A—coronary artery disease	5.71e-06	9.14e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—C3—coronary artery disease	5.7e-06	9.13e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	5.62e-06	9e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—C3—coronary artery disease	5.61e-06	8.99e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	5.5e-06	8.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—C3—coronary artery disease	5.49e-06	8.8e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HIF1A—coronary artery disease	5.44e-06	8.71e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGT—coronary artery disease	5.42e-06	8.68e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HIF1A—coronary artery disease	5.35e-06	8.57e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGT—coronary artery disease	5.33e-06	8.54e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LEP—coronary artery disease	5.31e-06	8.5e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOE—coronary artery disease	5.31e-06	8.5e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOA1—coronary artery disease	5.25e-06	8.4e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	5.24e-06	8.39e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOE—coronary artery disease	5.22e-06	8.37e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LEP—coronary artery disease	5.22e-06	8.37e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGT—coronary artery disease	5.22e-06	8.36e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KDR—coronary artery disease	5.2e-06	8.33e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK14—coronary artery disease	5.17e-06	8.27e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOA1—coronary artery disease	5.16e-06	8.27e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KDR—coronary artery disease	5.12e-06	8.2e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LEP—coronary artery disease	5.11e-06	8.19e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOE—coronary artery disease	5.11e-06	8.19e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	5.08e-06	8.14e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ESR1—coronary artery disease	5.07e-06	8.12e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	5.06e-06	8.1e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KDR—coronary artery disease	5.01e-06	8.02e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—F2—coronary artery disease	5.01e-06	8.02e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FN1—coronary artery disease	5.01e-06	8.02e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ESR1—coronary artery disease	4.99e-06	7.99e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6ST—coronary artery disease	4.99e-06	7.99e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	4.98e-06	7.97e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	4.95e-06	7.92e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—F2—coronary artery disease	4.93e-06	7.89e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FN1—coronary artery disease	4.93e-06	7.89e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	4.91e-06	7.86e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	4.88e-06	7.82e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	4.87e-06	7.8e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—F2—coronary artery disease	4.82e-06	7.72e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FN1—coronary artery disease	4.82e-06	7.72e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	4.8e-06	7.69e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KIT—coronary artery disease	4.79e-06	7.67e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	4.77e-06	7.63e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KIT—coronary artery disease	4.71e-06	7.55e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KIT—coronary artery disease	4.62e-06	7.39e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GSK3B—coronary artery disease	4.6e-06	7.36e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—POMC—coronary artery disease	4.56e-06	7.3e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CREB1—coronary artery disease	4.56e-06	7.3e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	4.52e-06	7.24e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—POMC—coronary artery disease	4.49e-06	7.19e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CREB1—coronary artery disease	4.49e-06	7.19e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL2—coronary artery disease	4.46e-06	7.15e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6R—coronary artery disease	4.45e-06	7.12e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	4.43e-06	7.09e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—POMC—coronary artery disease	4.39e-06	7.04e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	4.39e-06	7.04e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL2—coronary artery disease	4.39e-06	7.03e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1—coronary artery disease	4.39e-06	7.03e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6R—coronary artery disease	4.38e-06	7.01e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	4.37e-06	6.99e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1—coronary artery disease	4.32e-06	6.91e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	4.3e-06	6.88e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	4.3e-06	6.88e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	4.29e-06	6.86e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	4.23e-06	6.77e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	4.21e-06	6.74e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.17e-06	6.68e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	4.17e-06	6.67e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.1e-06	6.57e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	4.1e-06	6.56e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF2—coronary artery disease	4.03e-06	6.46e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.02e-06	6.44e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	4.01e-06	6.43e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOS3—coronary artery disease	3.98e-06	6.37e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF2—coronary artery disease	3.97e-06	6.35e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOS3—coronary artery disease	3.91e-06	6.27e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	3.88e-06	6.22e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—JAK2—coronary artery disease	3.86e-06	6.19e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	3.83e-06	6.14e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—JAK2—coronary artery disease	3.8e-06	6.09e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	3.79e-06	6.07e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	3.73e-06	5.97e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	3.72e-06	5.96e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.65e-06	5.85e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL8—coronary artery disease	3.53e-06	5.65e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	3.47e-06	5.56e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	3.41e-06	5.46e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	3.4e-06	5.44e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CASP3—coronary artery disease	3.38e-06	5.41e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—coronary artery disease	3.35e-06	5.37e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	3.35e-06	5.37e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CASP3—coronary artery disease	3.32e-06	5.32e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—coronary artery disease	3.3e-06	5.29e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCND1—coronary artery disease	3.29e-06	5.26e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	3.28e-06	5.26e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	3.25e-06	5.21e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCND1—coronary artery disease	3.23e-06	5.18e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	3.23e-06	5.18e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—coronary artery disease	3.19e-06	5.11e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	3.17e-06	5.07e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—coronary artery disease	3.14e-06	5.03e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT1—coronary artery disease	3.09e-06	4.96e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	3.07e-06	4.92e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	3.04e-06	4.88e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	2.98e-06	4.78e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—coronary artery disease	2.86e-06	4.59e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	2.82e-06	4.51e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	2.76e-06	4.42e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFB1—coronary artery disease	2.63e-06	4.21e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	2.59e-06	4.14e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK1—coronary artery disease	2.58e-06	4.13e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	2.54e-06	4.06e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	2.53e-06	4.06e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	2.48e-06	3.98e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	2.24e-06	3.58e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	2.2e-06	3.53e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	2.16e-06	3.45e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—coronary artery disease	1.98e-06	3.17e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—coronary artery disease	1.95e-06	3.12e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—coronary artery disease	1.91e-06	3.06e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT1—coronary artery disease	1.83e-06	2.93e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT1—coronary artery disease	1.8e-06	2.88e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	1.76e-06	2.82e-05	CbGpPWpGaD
